ClinicalTrials.gg
Drug

Seribantumab clinical trials

Also written MM-121 and SAR256212.

studies test it
13
open now
0
in phase 3
0
first study started
2008

How each study uses seribantumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Seribantumab
4
Seribantumab, SAR256212
3

Development codes

MM-121
10
SAR256212
4

Studies by the year they started

13 studies that test it; most in 2011 (4)

Studies that test seribantumab, by start year
YearStudies
20081
20103
20114
20152
20171
20201
20211

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 1

Merrimack Pharmaceuticals (8) · Elevation Oncology (3) · Ottawa Hospital Research Institute (1) · Sanofi (1)

Often tested with

Tested in the same studies.

Cetuximab (1) · XL147 (1) · Istiratumab (1)

Studies

Open first, then newest update. How each study uses seribantumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Given beside what is tested · 1 — seribantumab is usual care or a partner of the new treatment

Codes

What other systems call seribantumab · ClinicalTrials.gg INT000024

  • MeSH (NLM) C000589319seribantumabOne source NLM
  • UNII (FDA) 1N3L70MDFXSERIBANTUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q19946112seribantumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C78859SeribantumabOne source FDA
  • DrugBank DB11857One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.